Seminar on Art of Cancer Care and Its Clinical Translation in China
04 Dec 2026
10.00 AM - 11.00 AM
LHN-TR+18 (The Arc, LHN-L1-06)
Current Students, Public
Dr Zhang Jun Professor and Chief Physician in the Department of Oncology, Ruijin Hospital Shanghai Jiao Tong University School of Medicine, China This seminar will be chaired by A/P Huang Changjin. | ||
| Seminar Abstract | ||
| Against substantial cancer burden pressure in China with ongoing cancer spectrum
transition, the Chinese Anti Cancer Association (CACA) advances full cycle cancer
governance spanning prevention, screening, diagnosis, treatment, rehabilitation and
survivorship, and promotes standardized whole journey supportive care practice. Clinical
translational bottlenecks remain a key unmet challenge. Anchored by the Mechanism
Empowered Ruijin Cancer Incubator (MERCI), Committee of Neoplastic Supportive-care
(CONS) and Ruijin Oncology Alliance advocates physician scientists as innovation chain
stewards and establishes three core pillars: biological cognition, precision therapeutic
decision making, and precision response evaluation. Centered on biology oriented clinical
decision making, our group addresses critical scientific challenges including organ specific
metastatic tropism and adaptive tumour evolution under therapeutic pressure.
Translational outputs include biomarker guided systemic therapy stratification and our
jointly developed OX40 agonist, whose phase I data received an oral presentation at the
2026 World Cancer Congress. This mechanism driven, patient centered paradigm delivers
actionable real world insights for China’s evolving oncology landscape. | ||
| Speaker's Biography | ||
|
